DRUG ALERT: Digitek
|
Beginning in early 2008, the FDA began receiving reports of illnesses and injuries in patients taking Digitek. Actavis said it had 11 such reports. But because not all adverse reactions are reported to the FDA or manufacturers, we believe that there are far more victims of this defective drug. Digitek, manufactured by Actavis Towtowa, is sold by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. Digitek is a form of digitalis, a chemical derived from the foxglove plant that has been used as a heart medicine since the 18th century. The medication is sold generically as digoxin by several companies.
Digitalis medicines strengthen the force of the heartbeat by increasing the amount of calcium in the heart's cells. When the medicine reaches the heart muscle, it binds to sodium and potassium receptors. These receptors control the amount of calcium in the heart muscle by stopping the calcium from leaving the cells. As calcium builds up in the cells, it causes a stronger heartbeat. Digitalis medicines also control irregular heart rhythms (called arrhythmias) by slowing the signals that start in the sinoatrial (SA) node. This, in turn, reduces the number of signals that travel through the atrioventricular (AV node). Fewer signals mean fewer arrhythmias.
Digitalis Toxicity is a known complication of digitalis therapy and may be caused by an acute ingestion of digitalis. Digitalis Toxicity can occur from long term use or even a single exposure or a chronic overmedication or overdosing. People with heart failure are commonly given diuretics (medications used to pull excess fluid from the body) along with digoxin. Many diuretics can cause potassium loss. It is important to understand that low levels of potassium in the body can increase the risk of Digitalis Toxicity. Digitalis Toxicity may also result from low levels of magnesium in the body. Reduced kidney function will cause digitalis to accumulate in the body rather than being excreted normally through urine. Therefore, any disorders that disrupt kidney functioning (including dehydration) make digitalis toxicity more likely.
Digitek Recall Notice: On April 25, 2008, Actavis Towtowa recalled its Digitek tablets because there existed a possibility that tablets with double the appropriate thickness may have been commercially released. The FDA deemed the Digitek recall a Class I recall, meaning that the defective Digitek tables could cause serious health problems or death. Our Digitek injury lawyers have determined that Actavis' failure to keep these Digitek tablets away from consumers constitutes an act of negligence, and we are determined to hold this manufacturer accountable.
A double-strength Digitek tablet poses a serious risk of digitalis toxicity in those patients suffering from renal failure. Digitalis toxicity can cause nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, heart palpitations, and bradycardia. Bradycardia is a slower than normal heartbeat rate.
IF YOU OR A LOVED ONE HAS SUFFERED AN INJURY, INCLUDING BUT NOT LIMITED TO DEATH, KIDNEY COMPLICATIONS, NAUSEA, VOMITING, DIARRHEA, DIZZINESS, CONFUSION, LOSS OF APPETITE, LOW BLOOD PRESSURE, CARDIAC INSTABILITY, IRREGULAR PULSE, HEART PALPITATIONS OR BRADYCARDIA – THEN CALL OUR LAW FIRM DAY OR NIGHT AT 1-800-862-1260.
TRADEMARK NOTICE: Digitek is a trademark of Actavis Totowa LLC.
The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Actavis Totowa LLC. The use of this mark is solely for informational and product identification purposes.


